Navigation Links
Global Renal Failure Partnering 2010 to 2016
Date:12/15/2016

LONDON, Dec. 14, 2016 /PRNewswire/ -- The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.

- Trends in partnering deals
- Top deals by value
- Deals listed by company A-Z, industry sector, stage of development, technology type

The report provides understanding and access to the partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This data driven report contains multiple links to online copies of actual deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

The initial chapters of this report provide an orientation of partnering trends.

Chapter 1 provides an overview of the trends in partnering since 2010, including a summary of deals by industry sector, stage of development, deal type, and technology type.

Chapter 2 provides a review of the top 10 most active companies in the therapy area, including a comprehensive listing of the deals announced by each company.

Chapter 3 provides a comprehensive directory of partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a listing of partnering deals where a contract document is available alongside the deal record.

Chapters 5 and 6 provide a summary of M&A deals since 2010 where the acquired company is active in the therapy area of interest.

Chapters 7 and 8 provide a summary of financings since 2010 where the financed company is active in the therapy area of interest.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products in the therapy area.

Download the full report: https://www.reportbuyer.com/product/3605699/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-renal-failure-partnering-2010-to-2016-300378863.html


'/>"/>
SOURCE ReportBuyer
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Information Online Market Research Portal Provides Complimentary Sample Service for Customers to Preview Reports by Global Industry Analysts
2. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
3. The Rockley Group and Content Rules Ink Deal to Extend Global Reach
4. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
5. Amgen To Present At The UBS Global Life Sciences Conference
6. HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
7. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City
8. PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems
9. Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
10. TRACE Releases 2012 Global Enforcement Report
11. Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2020)... ... ... Exercise.com, the fitness industry’s leading tech company specializing in all-in-one business software ... software during the months of May and June. This announcement highlights the growing demand ... gym giants like 24 Hour Fitness and Gold’s Gym are ...
(Date:7/2/2020)... SPRINGS, Miss. (PRWEB) , ... July 02, 2020 ... ... Springs, Mississippi-based wholesale pharmaceutical distributor, is pleased to announce its donation of more ... and the Michigan Department of Health and Human Services. As extreme medical shortages ...
(Date:7/1/2020)... ... 01, 2020 , ... Lumeda Inc. (“Lumeda”), a ... formation of its Scientific Advisory Board with the appointment of a panel of ... to support company development and introduction of its PDT products to the clinic. ...
Breaking Medicine Technology:
(Date:6/25/2020)... ... , ... Denials Management, Inc. has just published The Health Insurance Appeals Guide ... denials of mental health and substance use disorder (MH/SUD) treatment services. It was written ... explain the steps in the appeals process. Complimentary copies of the Guide can ...
(Date:6/24/2020)... ... ... Dr. Katinka van der Merwe, the creator of the world’s leading 12 week ... Grace podcast. She explains her outside-the-box, holistic approach to treating CRPS and how important ... diagnosed with CRPS about 10 years ago, Amberly Lago , the host of ...
(Date:6/24/2020)... , ... June 24, 2020 , ... Skyroam , ... a partnership with LabWare , the leading provider of enterprise software for testing ... connectivity as part of LabWare’s new Portable Disease Surveillance Lab (PDSL) kit. , “Stopping ...
(Date:6/23/2020)... ... 2020 , ... Anesthesia Progress —Receiving dental care during ... virus, which is primarily found in oral, nasal, and pharyngeal mucosa and in ... or by aerosols produced during aerosol-generating procedures (AGPs). Given the transmission type, four ...
(Date:6/23/2020)... ... June 22, 2020 , ... In its latest ... and forecasts for the market for tests tied to therapeutic selection or effectiveness. ... in hospitals, as well as pharmaceutical companies serving them to determine recent market trends. ...
Breaking Medicine News(10 mins):